Puma Biotechnology Announces Publication of Abstracts on Neratinib for the AACR Annual Meeting 2017

FJ Carmona, D Hyman, G Ulaner, J Erinjeri, N Bouvier, R Cutler, A Alani, M Berger, J Baselga, L Joenson,CW Yde, O Østrup, M Mau-Sørensen,FC Nielsen, U Lassen,J Meade, M Glassman,A Moriarty, D Rasco,A Patnaik,KP Papadopoulos

semanticscholar（2019）

引用 0|浏览4

暂无评分

摘要

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced publicat ion of abstracts on neratinib for the American Associat ion for Cancer Research (AACR) Annual Meeting 2019. The AACR Annual Meeting will be held at the Georgia World Congress Center in Atlanta, Georgia from March 29 to April 3. Posters will be available on Puma’s website following presentation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要